Salix Pharmaceuticals, Ltd., headquartered in Raleigh, North Carolina, develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases. Salix's strategy is to in-license late-stage or marketed proprietary therapeutic drugs, complete any required development and regulatory submission of these products, and market them through the Company's 150-member gastroenterology specialty sales and marketing team.

Contact Information

1700 Perimeter Park Drive
Morrisville, NC 27560

tel: 919-862-1000
fax: 919-862-1095


Investor Relations



Exchange: NASDAQ
Industry: Drug Related Products
Market Cap: $323.7M

The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases. Please see our Disclaimer and Terms of Service for more information.